NCT06995326View on ClinicalTrials.gov

A Study of SGB-3383 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

January 31, 2027

Conditions

Healthy Volunteers

Interventions

DRUG

SGB-3383

SGB-3383 for sc injection, single dose

DRUG

SGB-3383-Matching placebo

SC injection, single dose

All Listed Sponsors

lead

Suzhou Sanegene Bio Inc.

INDUSTRY